The MLL gene, located on chromosome band 11q23 is fused to different partner genes as a result of various chromosomal translocations in hematopoietic malignancies. A t(1;11) (q21;q23) resulting in a MLL-AF1q fusion gene has previously been reported. Cytogenetic studies on six cases are reported, including one three-way translocation. FISH analysis using a YAC encompassing the MLL gene and a YAC encompassing the AF1q locus showed splitting in three cases and two patients, respectively. PCR analysis of two cases confirmed that AF1q is specifically associated with t(1;11)(q21;q23). The MLL-AF1q fusion mRNA was similar to that previously described in one case and involved MLL exon 7 in the other. This study confirms the specific involvement of AF1q in t(1;11) (q21;q23)-positive acute leukemia with monocytic involvement.
Introduction
The chromosomal band 11q23, where the MLL gene is located, is nonrandomly rearranged with about 30 other bands in chromosomal abnormalities of malignant blood disorders. 1, 2 Most of the rearrangements of 11q23 in acute leukemias cluster within a region of 8.3 kb and result in a fusion of the MLL gene with a partner gene on the other chromosome. [1] [2] [3] Seventeen of these chimeric genes have been identified to date. [3] [4] [5] [6] [7] [8] [9] [10] Identification of other partners of MLL is now in progress in order to try to understand the consequences of the fusion of MLL to so many various partner genes. The incidence of the various translocations involving MLL seems to be different for the different types of rearrangement. For instance, 281 acute lymphoblastic leukemias (ALL) with t(4;11)(q21;q23) were collected by Mitelman et al 11 while only six cases of acute myeloblastic leukemia (AML) with t(1;11)(q21;q23) were listed in the same article. Two t(1;11)(q21;q23) translocations were shown to recombine the MLL gene on 11q23 with the AF1q on chromosome 1. 12 The contribution of AF1q to the fusion protein is only of 90 amino acids, and the function of AF1q is not yet known.
As exemplified by the t(11;19)(q23;p13) translocation, it is known that different genes (ENL, ELL, EEN) located on the same chromosome band may be fused with MLL. 8, 13, 14 Several genes, AFIq, BCL9 on 1q21 12, 15 may be recombined by different translocations seen in hematopoietic malignancies. Molecular techniques are needed to establish the recurrence of gene fusions in such translocations.
We now report three new cases of acute leukemia with t(1;11)(q21;q23), in addition to three other cases (Nos 1-3) previously published. [16] [17] [18] Correspondence: R 
Materials and methods

Patients
Clinical and hematological data of six patients studied in the laboratory are summarized in Table 1 . All were children (four infants), three with AML-M4 in the FAB nomenclature, two with AML-M5 and one with AML-M1/M2. Five relapsed and one was still in complete remission 15 months after autograft.
Cytogenetic studies
Chromosome studies were performed on bone marrow and/or unstimulated blood cultures at diagnosis, and in relapse in five patients, and in remission in one. RHG and/or GTG bands were obtained and the karyotype classified according to the International Nomenclature.
Fluorescence in situ hybridization (FISH) studies
FISH studies were performed on metaphase chromosomes in three patients (Nos 3, 5, 6) using YAC 742f9 (CEPH library) as a probe. This YAC is currently used in the laboratory to detect possible MLL involvement in 11q23 translocations. YAC 978e4 (CEPH library) which covers the AF1q locus and gives a strong hybridization locus on band 1q21 in spite of its chimerism was also used. More recently, a BAC from the CEPH library, 767A8, identified as containing AF1q sequences was also used.
Molecular studies
Molecular studies were performed in two patients (Nos 5 and 6).
Nucleic acid analysis:
RNA was isolated using Trizol reagent (Gibco BRL, Cergy-Pontoise, France), following the manufacturer's instructions and processed using standard protocols. 18 
PCR experiments:
Taking advantage of the apparent similarity between the present case and the chromosomal rearrangement that led to the isolation of the AF1q gene, 12 we reasoned that a similar molecular rearrangement could be present. RNA and then cDNA were obtained from blood cells of the patient (Kit Gibco BRL) and a polymerase chain reaction (PCR) was carried out. The primers used were: CACTCCTAGTGAGCCCAAG (MLL exon 5), CCCAAG-TATCCCTGTAAAACA (MLL exon 6), TCAGCACTCTCTC- Table 1 for more data.
Figure 1
Partial karyotypes of patients 1 to 6 (see Table 1 ) showing the t(1;11)(q21;q23). R bands (R) and G bands (G). Arrows show the rearranged chromosomes.
CAATGG (MLL exon 7), GGTTCGAAGTCTTGGCCTTA-GAGCA (AF-1qR) corresponding to AF1q sequences. 12 Amplification of the fragments was performed as follows: denaturation was undertaken at 94°C for 5 min in the first cycle, and for 1 min in the subsequent cycles. Annealing steps were performed for 10 s at 62°C (four cycles), 58°C (four cycles) and 52°C (30 cycles) and extension at 72°C for 1 min. Nucleotide sequence was obtained from a commercial source.
Results
Chromosome studies
Rearrangement of bands 1q21 and 11q23 was present in the six patients (Figure 1 ), t(1;11)(q21;q23) in five and t(1;11;3) (q21;q23;q21) in one ( Table 2) . A triplo-X constitution was detected in case 1. It was thought to be constitutional since karyotypes 47,XXX were observed in relapse in addition to those with 47,XXX,t(1;11).
FISH
Three hybridization signals, one on the normal chromosome 11 and one each of the rearranged chromosomes (1q− and 11q+) were observed on metaphase cells using YAC 742f9 as the probe for patients 3, 5 and 6. This YAC splitting favored the existence of the MLL rearrangement. A clear splitting of the signals was observed using YAC 978e4 as a probe in patients 1, 3 and 5, suggesting a possible rearrangement of AF1q. Similarly, three spots, on normal one and on the two rearranged chromosomes, were observed in the metaphases of patient 6 with BAC 767A8, confirming the involvement of AF1q. FISH analysis was not performed in other patients because of the shortage of material.
PCR studies
In order to detect putative MLL-AF1q fusion transcripts, we performed PCR analysis of random-primed patients 5 and 6 cDNA using MLL primers corresponding to exon 5, 6 and 7, and a AF1q-specific oligonucleotide. As shown in Figure 2 , a 411 bp fragment was specifically amplified from patient 6 material using MLL Ex5 primer (panel a), a 327 bp fragment was seen using MLL Ex6 (panel b) and no amplification product using MLL Ex7 primer (panel c). These result were in good agreement with a MLL Ex6-AF1q fusion, as previously reported.
The fragments amplified using patient 5 material were slight larger, 543 bp with MLLEx5 primer (panel a), and 459 bp using MLL Ex 6 primer (panel b). In addition a specific 370 bp fragment was amplified using a MLL Ex7 primer (panel c), indicating that the fusion could have occurred downstream of MLL Ex7.
As shown in Figure 3 , nucleotide sequence analysis confirmed an in frame fusion of MLL exon 7 to AF1q, 5Ј of its putative translational start codon.
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Discussion
The chromosomal band 11q23 is frequently rearranged in malignant blood disorders and MLL gene rearrangements are the most often implicated in acute leukemias. Fusion of MLL with other genes results from various chromosomal translocations and 17 different fusion genes, including MLL selffusion, have been described in hematopoietic malignancies. The incidence of each translocation is variable due in part to the relative difficulty of identification with banding techniques as for example, t(6;11)(q27;q23), 20 the apparent variability of the breakpoints on banded chromosomes as for t(10;11)(p12;q23), 21 or because the incidence of some translocations is really low. Translocation t(1;11)(q21;q23) is an Amplification of MLL-AF1q fused transcripts from t(1;11) patients. PCR experiments were performed with the sets of primers indicated at the bottom of the figure (see text) . The size of the amplified fragment is indicated in base pairs (bp). The patient number is indicated at the top of the figure, unrelated cDNA (negative control).
Figure 3
Nucleotide sequence of fused MLL-AFIq cDNA and corresponding sequences of normal chromosomes 11 and 1. Conceptual translation of normal cDNA is shown. AF1q sequences appear in lower case letters. The predicted AF1q transcriptional start codon is underlined. Arrows indicate the fusion point, 3Ј of MLL exon 7. example of such an infrequent rearrangement since only a few cases have previously been reported in acute myeloid and acute lymphoid leukemia and myelodysplastic syndrome (Table 3 ). Molecular analysis of two of these cases, two acute myelomonocytic leukemias in infants, has allowed the isolation of a new gene, named AF1q, fused with MLL. 12 The AF1q gene encodes a 9 kDa protein without apparent similarity to any other protein and is expressed in normal thymus and myeloid cells. 12 The presence of an MLL-AF1q fusion gene has not been described in other t(1;11)(q21;q23) of hematopoietic malignancies. The present study confirms the nonrandomness of the specific MLL-AF1q rearrangement as well as the similar mRNA fusion pattern as described before. However, the direct proof of MLL involvement in most of the cases previous described is lacking. This involvement in other 1q21 rearrangements of malignant proliferations remains to be studied.
